FDA advisors back GlaxoSmithKline RSV vaccine for older adults ...Middle East

The Hill - News
FDA advisors back GlaxoSmithKline RSV vaccine for older adults
A Food and Drug Administration (FDA) advisory panel on Wednesday recommended the second vaccine for respiratory syncytial virus (RSV) in older adults in as many days, setting up a race between manufacturers looking to bring the first-of-its-kind shot to market. The 12-member panel voted 10-2 that the vaccine developed by GlaxoSmithKline is safe, and separately voted unanimously that data show the shot is effective. Similar to data presented Tuesday for a vaccine manufactured by Pfizer, some panel members had concerns about nervous system disorders like Guillain-Barré syndrome that may be tied to the shot.   "For a vaccine that could be potentially recommended every year for every

Hence then, the article about fda advisors back glaxosmithkline rsv vaccine for older adults was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA advisors back GlaxoSmithKline RSV vaccine for older adults )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News